✦ LIBER ✦

475 Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of lamivudin

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

504 Twenty-four months combination thera

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Lamivudine compared with lamivudine and

✍ Joseph J.Y. Sung; Jak-Yiu Lai; Stefan Zeuzem; Wan Chen Chow; E. Jenny Heathcote; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB

558 COST-EFFECTIVENESS SIMULATION ANALYS

✍ B. Deniz; M. Buti; M. Brosa; M.A. Casado; M. Rueda; F. Everhard; R. Esteban 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Comparative meta-analysis of adefovir di

✍ YongFa Chen; Ting Ju 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 1004 KB

521 Long-term antiviral therapy with lam

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB